Howard J. Dreskin
Corporate Officer/Principal at Optimer Pharmaceuticals LLC
Network origin in Howard J. Dreskin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ.
37
| Subsidiary | Pharmaceuticals: Major | 37 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Howard J. Dreskin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Rutgers State University of New Jersey | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Chief Administrative Officer Corporate Officer/Principal Director of Finance/CFO | |
| Fu Jen Catholic University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| OBI PHARMA, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Pennsylvania | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NU SKIN ENTERPRISES, INC. | Household/Personal Care | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| EAGLE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Brandeis University | College/University | Doctorate Degree Doctorate Degree | |
Tioga Pharmaceuticals, Inc.
 Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Bellevue Asset Management (Venture Capital)
 Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Investment Managers | Private Equity Investor | |
| WOODBROOK GROUP HOLDINGS INC. | Investment Managers | Chairman | |
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
| Bayer Pharma France SA | Chief Tech/Sci/R&D Officer | ||
| Abbott International LLC | Chief Tech/Sci/R&D Officer | ||
| Asphelia Pharmaceuticals, Inc. | President | ||
TAP Pharmaceutical Products, Inc.
 TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Abbotts Ltd.
 Abbotts Ltd. Real Estate DevelopmentFinance Abbotts Ltd. is a British company that provides real estate services. The private company is based in Clacton On Sea, UK. The CEO of the company is Harry Douglas Hill. | Real Estate Development | Chief Tech/Sci/R&D Officer | |
Biotech Ventures GP Ltd.
 Biotech Ventures GP Ltd. Financial ConglomeratesFinance Part of Bellevue Group AG, Biotech Ventures GP Ltd. is a venture capital fund. The company is based in St. Peter Port, UK. | Financial Conglomerates | Corporate Officer/Principal | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
Binx Health Ltd.
 Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Delaware | College/University | Undergraduate Degree | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ipsen, Inc.
 Ipsen, Inc. Industrial MachineryProducer Manufacturing Ipsen, Inc. design and manufacture of industrial atmosphere and vacuum heat-treating systems and supervisory controls systems. It offers vacuum furnaces, atmosphere furnaces, and PdMetrics software platform. The company was founded by Harold Ipsen in 1948 and is headquartered in Cherry Valley, IL. | Industrial Machinery | Corporate Officer/Principal | |
CenterLight Health System, Inc.
 CenterLight Health System, Inc. Medical/Nursing ServicesHealth Services CenterLight Health System, Inc. provides residential and community-based health care services. Its services include nursing, rehabilitation, medical , adult day health care, home health care, housing and music therapy. The company was founded by Bertha Alperstein in 1920 and is headquartered in Bronx, NY. | Medical/Nursing Services | Director/Board Member | |
Sarah Cannon Research Institute LLC
 Sarah Cannon Research Institute LLC Miscellaneous Commercial ServicesCommercial Services Sarah Cannon Research Institute LLC offers management, regulatory and other research support services for drug development. It is one of the largest clinical research programs, conducting community-based clinical trials in oncology, cardiology, gastroenterology and other therapeutic areas through affiliations with a network of physicians. The company was founded by John D. Hainsworth and F. Anthony Greo in 1993 and is located in Nashville, TN. | Miscellaneous Commercial Services | Director/Board Member | |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Ariceum Therapeutics GmbH
 Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Pureos Partners AG
 Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investment Managers | Private Equity Investor | |
binx health, inc.
 binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Information Technology Services | Director/Board Member | |
Alentis Therapeutics AG
 Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 36 |
| Switzerland | 6 |
| France | 4 |
| United Kingdom | 4 |
| Taiwan | 3 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 5 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 191 |
| Corporate Officer/Principal | 84 |
| Independent Dir/Board Member | 60 |
| Chief Tech/Sci/R&D Officer | 39 |
| Undergraduate Degree | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Henry McKinnell | 35 |
| Robert Perez | 31 |
| Howard Lee | 27 |
| Alain B. Schreiber | 25 |
| Stephen Webster | 23 |
| Cynthia Flowers | 22 |
| Martin C. Münchbach | 20 |
| Anthony Altig | 19 |
| Stephen L. Newman | 18 |
| Robert Zerbe | 18 |
| Pedro Lichtinger | 16 |
| Thomas DesRosier | 15 |
| Mark Auerbach | 15 |
| Rachel Stahler | 14 |
| Peter E. Grebow | 12 |
- Stock Market
- Insiders
- Howard J. Dreskin
- Company connections
